Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer.
Saved in:
| Title: | Cardiac safety results from a phase II, open-label, multicenter, pilot study of two docetaxel-based regimens plus bevacizumab for the adjuvant treatment of subjects with node-positive or high-risk node-negative breast cancer. |
|---|---|
| Authors: | Hurvitz SA; University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 USA., Bosserman LD; Wilshire Oncology Medical Group, Inc., La Verne, CA USA., Chan D; Torrance Memorial Hospital, Redondo Beach, CA USA., Hagenstad CT; Suburban Hematology and Oncology, Lawrenceville, GA USA., Kass FC; Cancer Center of Santa Barbara, Santa Barbara, CA USA., Smith FP; Georgetown University School of Medicine, Washington, DC USA., Rodriguez GI; South Texas Oncology and Hematology, P.A., San Antonio, TX USA., Childs BH; sanofi U.S., Bridgewater, NJ USA., Slamon DJ; University of California, Los Angeles, 10945 Le Conte Avenue, PVUB Suite 3360, Los Angeles, CA 90095 USA. |
| Source: | SpringerPlus [Springerplus] 2014 May 12; Vol. 3, pp. 244. Date of Electronic Publication: 2014 May 12 (Print Publication: 2014). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SpringerPlus Country of Publication: Switzerland NLM ID: 101597967 Publication Model: eCollection Cited Medium: Print ISSN: 2193-1801 (Print) Linking ISSN: 21931801 NLM ISO Abbreviation: Springerplus Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
